Dr. Pol Bamelis Appointed Devgen NV Board Member

September 25, 2006 |

1 min read

GENT-ZWIJNAARDE, BELGIUM -- (MARKET WIRE) -- September 25, 2006 -- Ghent, Belgium, September 25, 2006 - Devgen (Euronext Brussels: DEVG) announces today that Dr. Pol Bamelis has been appointed member of the board on September 22nd.

People Europe

MORE ON THIS TOPIC

Legal and law concept illustration stock illustration

GLP-1

Novo Sues Hims & Hers Over Compounded Version of Oral Wegovy Pill

February 9, 2026

·

2 min read

·

Tristan Manalac

Business meeting idea and planning with strategy as a corporate concept with a mechanical wheel bridge as diverse multiracial businesspeople joining together as a symbol for people diversity and success with 3D render elements.

Earnings

Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline

February 6, 2026

·

2 min read

·

Annalee Armstrong

IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch

IPO

Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow

February 6, 2026

·

5 min read

·

Tristan Manalac

FDA Commissioner Dr. Marty Makary delivers remarks after President Donald Trump made an announcement on drug pricing, Tuesday, September 30, 2025, in the Oval Office. (Official White House Photo by Joyce N. Boghosian)

GLP-1

Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill

February 6, 2026

·

1 min read

·

Tristan Manalac